These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9229959)

  • 21. Liposomal antisense oligonucleotides for cancer therapy.
    Siwak DR; Tari AM; Lopez-Berestein G
    Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168
    [No Abstract]   [Full Text] [Related]  

  • 22. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ribosomal protein P2: a potential molecular target for antisense therapy of human malignancies.
    Gardner-Thorpe J; Ito H; Ashley SW; Whang EE
    Anticancer Res; 2003; 23(6C):4549-60. PubMed ID: 14981896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-conjugated antisense therapy takes a skip ahead.
    Wells DJ
    Mol Ther; 2008 Sep; 16(9):1523-4. PubMed ID: 18725878
    [No Abstract]   [Full Text] [Related]  

  • 26. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular approaches to cancer therapy.
    Israel MA
    Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720
    [No Abstract]   [Full Text] [Related]  

  • 28. Antisense tumor therapy (a dream under construction).
    Kopper L; Kovalszky I
    In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European School of Oncology Task Force Papers: gene therapy--a future in cancer management? Antisense therapy for malignant disease.
    O'Brien SG; Kirkland MA; Goldman JM
    Eur J Cancer; 1994; 30A(8):1160-4. PubMed ID: 7654449
    [No Abstract]   [Full Text] [Related]  

  • 30. 10 years and counting: the hype and hope of cancer biotechnology.
    Morris K
    Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706
    [No Abstract]   [Full Text] [Related]  

  • 31. Antisense technology and prospects for therapy of viral infections and cancer.
    Wagner RW; Flanagan WM
    Mol Med Today; 1997 Jan; 3(1):31-8. PubMed ID: 9021740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 33. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antisense against cancer?]].
    Edris E; Möller AM; Oberhauser EM; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2010 May; 39(3):170-1. PubMed ID: 20425764
    [No Abstract]   [Full Text] [Related]  

  • 35. Antisense therapy: therapeutic magic bullet or theoretical dream?
    Turner C
    Clin Oncol (R Coll Radiol); 1997; 9(1):54-8. PubMed ID: 9039815
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential use of radiolabeled antisense oligonucleotides in oncology.
    Gauchez AS; Du Moulinet D'Hardemare A; Lunardi J; Vuillez JP; Fagret D
    Anticancer Res; 1999; 19(6B):4989-97. PubMed ID: 10697501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligonucleotide pharmacotherapy: an antigene strategy.
    Nagel KM; Holstad SG; Isenberg KE
    Pharmacotherapy; 1993; 13(3):177-88. PubMed ID: 8321732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
    Kausch I; Böhle A
    Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancements of antisense oligonucleotides in treatment of breast cancer.
    Yang SP; Song ST; Song HF
    Acta Pharmacol Sin; 2003 Apr; 24(4):289-95. PubMed ID: 12676065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNAi: a novel antisense technology and its therapeutic potential.
    Dallas A; Vlassov AV
    Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.